Cue Biopharma, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -67.4% | -67.4% | -53.0% |
| FY2022 | -80.7% | -71.9% | -58.1% |
| FY2023 | -136.8% | -122.9% | -82.5% |
| FY2024 | -232.4% | -232.4% | -126.4% |
| FY2025 | -100.6% | -100.6% | -63.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -67.4% | -67.4% | -53.0% |
| FY2022 | -80.7% | -71.9% | -58.1% |
| FY2023 | -136.8% | -122.9% | -82.5% |
| FY2024 | -232.4% | -232.4% | -126.4% |
| FY2025 | -100.6% | -100.6% | -63.0% |